ESC 365 - When innovation and evidence disrupt the TAVI landscape

ESC2025 Premium Access

When innovation and evidence disrupt the TAVI landscape

Session: How the new guidelines and innovations impact the daily management of patients with heart valves diseases

Topic: Valvular Heart Disease

Speaker: Professor N. van Mieghem (Rotterdam, NL)

Sponsored by Abbott

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Nicolas van Mieghem

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

20 presentations

5 followers

4 more presentations in this session

Session introduction

Speaker: Professor B. Assmus (Giessen, DE) Professor D. Capodanno (Catania, IT)

New Guidelines and their impact on heart valve therapies

Speaker: Professor R. von Bardeleben (Mainz, DE)

When durable TEER outcomes are supported by proven technologies

Speaker: Professor M. Kessler (Ulm, DE)

Key learnings

Speaker: Professor B. Assmus (Giessen, DE) Professor D. Capodanno (Catania, IT)

Access the full session

How the new guidelines and innovations impact the daily management of patients with heart valves diseases

Speakers: Professor N. van Mieghem, Professor B. Assmus, Professor D. Capodanno, Professor R. von Bardeleben, Professor M. Kessler...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources